CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence

被引：1
|
作者：
Tan, Xiu Xia Sherry [1 ]
Maltez, Melissa [1 ]
Mallick, Ranjeeta [2 ]
Hamelin, Linda [1 ]
McDiarmid, Sheryl [1 ]
Kennah, Michael [1 ]
Atkins, Harold [1 ]
Kekre, Natasha K. [1 ]
机构：
[1] Ottawa Hosp, Dept Med, Ottawa, ON, Canada
[2] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Efficacy and Safety of CD19-Targeted CAR-T Cell Therapy for Refractory/Relapsed B-Cell Lymphoma: A Single Center of Real World Data
    Huang, Jing
    Fei, Jia
    Ou, Ruiming
    Liu, Zhi
    Zheng, Liling
    Zhu, Yangmin
    Shen, Huijuan
    Du, Yuanyuan
    Zhou, Qinjun
    Chen, Jiali
    Zhou, Changhua
    Yan, Rongrong
    Wang, Jiale
    Liu, Shuang
    Zhang, Qing
    BLOOD, 2021, 138
  • [22] Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma
    Kambhampati, Swetha
    Merryman, Reid W.
    Wang, Yan
    Bezerra, Evandro
    Voorhees, Timothy
    Falade, Ayo S.
    Seshadri, Madhav R.
    Bailey, Megumi
    Bailey, Neil
    Patel, Krish
    Andreadis, Charalambos
    Kittai, Adam S.
    Jacobson, Caron A.
    Palmer, Joycelynne Michelle
    Brown, Annette
    Herrera, Alex F.
    Budde, L. Elizabeth
    BLOOD, 2023, 142
  • [23] Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma
    Kambhampati, Swetha
    Merryman, Reid W.
    Wang, Yan
    Gaulin, Charles
    Bezerra, Evandro
    Voorhees, Timothy
    Seshadri, Madhav R.
    Falade, Ayo S.
    Habib, Alma
    Ayers, Amy A.
    Bailey, Megumi
    Brown, Annette
    Bailey, Neil
    Patel, Krish
    Andreadis, Charalambos
    Kittai, Adam S.
    Jacobson, Caron A.
    Palmer, Joycelynne Michelle
    Forman, Stephen J.
    Nastoupil, Loretta
    Budde, Lihua E.
    BLOOD, 2024, 144 : 526 - 526
  • [24] The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
    Spanjaart, Anne M.
    Pennings, Elise R. A.
    Mutsaers, Pim G. N. J.
    van Dorp, Suzanne
    Jak, Margot
    van Doesum, Jaap A.
    de Boer, Janneke W.
    Niezink, Anne G. H.
    Kos, Milan
    Vermaat, Joost S. P.
    Sijs-Szabo, Aniko
    van der Poel, Marjolein W. M.
    Nijhof, Inger S.
    Kuipers, Maria T.
    Chamuleau, Martine E. D.
    Lugtenburg, Pieternella J.
    Doorduijn, Jeanette K.
    Serroukh, Yasmina I. M.
    Minnema, Monique C.
    van Meerten, Tom
    Kersten, Marie Jose
    CANCERS, 2023, 15 (17)
  • [25] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients With Relapsed or Refractory Large B-Cell Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 15 - 17
  • [26] Safety of Axicabtagene Ciloleucel CD19 CAR T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma
    Sano, Dahlia
    Nastoupil, Loretta J.
    Fowler, Nathan H.
    Fayad, Luis
    Hagemeister, F. B.
    Lee, Hun Ju
    Samaniego, Felipe
    Wang, Michael
    Rodriguez, Maria Alma
    Iyer, Swaminathan P.
    Parmar, Simrit
    Steiner, Raphael
    Nair, Ranjit
    Adkins, Sherry
    Arafat, Sara
    Rao, Ahalya
    Vallejo, Liliana
    Hawkins, Misha
    Chen, Yiming
    Westin, Jason R.
    Neelapu, Sattva S.
    BLOOD, 2018, 132
  • [27] Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
    Chihara, Dai
    Liao, Laura
    Tkacz, Joseph
    Franco, Anjali
    Lewing, Benjamin
    Kilgore, Karl M.
    Nastoupil, Loretta J.
    Chen, Lei
    BLOOD, 2023, 142 (12) : 1047 - 1055
  • [28] CD19-specific CAR-T cell therapy for relapsed/refractory non-B-cell acute leukaemia with CD19 antigen expression
    Liu, Shuangyou
    Yin, Zhichao
    Yu, Xinjian
    Zhao, Yongqiang
    Pan, Jing
    Song, Yanzhi
    EUROPEAN JOURNAL OF CANCER, 2021, 153 : 1 - 4
  • [29] Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
    Hirayama, Alexandre Vinaud
    Fiorenza, Salvatore
    Gauthier, Jordan
    Voutsinas, Jenna M.
    Wu, Qian Vicky
    Kimble, Erik L.
    Pender, Barbara S.
    Kirchmeier, Delaney R.
    Di, Henna A.
    Cassaday, Ryan D.
    Chapuis, Aude G.
    Green, Damian J.
    Kiem, Hans-Peter
    Milano, Filippo
    Shadman, Mazyar
    Till, Brian G.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2022, 140 : 7447 - 7449
  • [30] A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)
    Larson, Sarah M.
    Chen, Yvonne Y.
    Johnston, Jim
    Roy, Sylvain
    Patel, Pinakin
    Benjamin, Jonathan E.
    BLOOD, 2023, 142
12345